Research and Development

Showing 15 posts of 9578 posts found.

texas-star

Texas launches lawsuit against FDA over lethal drug shipment

January 4, 2017 Medical Communications, Research and Development FDA, texas

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …
novartis_window

Greek authorities raid Novartis’ offices after bribery allegations

January 4, 2017 Medical Communications, Research and Development Greece, Greek, Novartis, bribery

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …
syringe

Sanofi and MSD end their joint vaccines partnership

January 3, 2017 Research and Development MSD, Sanofi, Sanofi pasteur msd

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …
giovanni_caforio

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
frederik_wilkinson

Impax Laboratories parts with CEO

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …
2017

Seven pharma trends for 2017

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …
jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

New research reverses HIV-related immune suppression

December 21, 2016 Research and Development HIV, UNC School of Medicine

The UNC School of Medicine has released new research which appears to offer a new approach to HIV treatment which …
fdaoutsideweb

FDA new drug approvals sink to six year low

December 21, 2016 Medical Communications, Research and Development FDA, NDA, new drug approvals

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016 Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …

Novartis seals two deals to bolster drug pipeline

December 21, 2016 Research and Development Conatus, Encore Vision, Novartis

Novartis has consolidated its ophthalmology position by acquiring Encore Vision, a Fort Worth-based US company. The company is focused on …
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …
The Gateway to Local Adoption Series

Latest content